- 全部删除
您的购物车当前为空
c-Met degrader-1 (Compound H11) 是一种口服活性的c-Met降解剂,利用泛素蛋白酶体系统进行降解,具有抗肝细胞癌 (HCC) 的活性,并能抑制 MHCC97H 异种移植瘤的生长。这种化合物可以抑制 HCC 细胞的增殖,阻止细胞周期进程,并诱导细胞凋亡 (Apoptosis)。此外,c-Met degrader-1 有可能克服细胞对 Ib 型 c-Met 抑制剂产生的耐药性。
c-Met degrader-1 (Compound H11) 是一种口服活性的c-Met降解剂,利用泛素蛋白酶体系统进行降解,具有抗肝细胞癌 (HCC) 的活性,并能抑制 MHCC97H 异种移植瘤的生长。这种化合物可以抑制 HCC 细胞的增殖,阻止细胞周期进程,并诱导细胞凋亡 (Apoptosis)。此外,c-Met degrader-1 有可能克服细胞对 Ib 型 c-Met 抑制剂产生的耐药性。

| 产品描述 | c-Met degrader-1 (Compound H11) is an orally active c-Met degrader that operates via the ubiquitin-proteasome system. It exhibits anti-hepatocellular carcinoma (HCC) activity and hampers tumor growth in MHCC97H xenografts. Additionally, c-Met degrader-1 suppresses the proliferation of HCC cells, disrupts the cell cycle, and induces apoptosis. It may also potentially overcome resistance to Type I c-Met inhibitors. |
| 分子式 | C45H53N7O3 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容